Home › Funds › Renaissance Technologies › DBD
Renaissance Technologies position in DBD
DIEBOLD NIXDORF INC · Miscellaneous
Latest position (Q2 2026)38.60K sh
Reported value held$3.28M
Portfolio Weight0.00%
First reportedQ4 2023
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 49.00K | $1.42K | New |
| Q1 2024 | 74.90K | $2.58K | Add |
| Q2 2024 | 249.70K | $9.61M | Add |
| Q3 2024 | 128.40K | $5.73M | Reduce |
| Q4 2024 | 79.70K | $3.43M | Reduce |
| Q1 2025 | 74.30K | $3.25M | Reduce |
| Q1 2025 | 74.30K | $3.25M | Reduce |
| Q2 2025 | 150.90K | $8.36M | Add |
| Q2 2025 | 150.90K | $8.36M | Add |
| Q3 2025 | 220.18K | $12.56M | Add |
| Q4 2025 | 101.70K | $6.90M | Reduce |
| Q1 2026 | 73.80K | $5.57M | Reduce |
| Q2 2026 | 38.60K | $3.28M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding DBD
- Capital World Investors 11.55M sh · $982.16M · Q2 2026
- BlackRock Inc 4.55M sh · $387.22M · Q2 2026
- Vanguard Group 1.96M sh · $133.03M · Q4 2025
- Geode Capital Management 842.28K sh · $71.63M · Q2 2026
- Arrowstreet Capital 468.04K sh · $39.79M · Q2 2026
- Charles Schwab Investment Management 355.33K sh · $30.21M · Q2 2026
- Morgan Stanley 303.95K sh · $25.84M · Q2 2026
- Fidelity Management & Research (FMR) 272.70K sh · $23.19M · Q2 2026
- Northern Trust Corp 270.99K sh · $23.04M · Q2 2026
- UBS Group AG 196.07K sh · $16.67M · Q2 2026
- Principal Global Investors 195.69K sh · $16.64M · Q2 2026
- Invesco Ltd 194.54K sh · $16.54M · Q2 2026